Study guide

7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA

Key Takeaways Explain This Topic AI

Single-breath DLCO is calculated using the Krogh equation, incorporating inspired volume (VI), breath-hold time (t), initial alveolar CO concentration (FA,CO,0 derived from tracer gas dilution), and final alveolar CO concentration (FA,CO,t).

Alveolar volume (VA) is determined simultaneously during the DLCO maneuver via single-breath dilution of the inert tracer gas (e.g., 10% He or Methane) and expressed in STPD/BTPS.

Anemia lowers DLCO due to reduced blood hemoglobin sink capacity, while polycythemia elevates DLCO; standard ATS/ERS formulas correct measured DLCO to a reference Hb of 13.4 g/dL (females/children) or 14.6 g/dL (adolescent/adult males).

Elevated carboxyhemoglobin (COHb) reduces DLCO through two mechanisms: a carboxyhemoglobin back-pressure effect that reduces the CO pressure gradient, and an anemia effect that ties up available binding sites on hemoglobin.

High altitude lowers ambient barometric pressure (PB), which reduces alveolar partial pressure of oxygen (PA,O2) and increases DLCO by decreasing competitive O2 binding at hemoglobin sites, requiring altitude/PB correction factors.

Last updated: August 2026

7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA

The interpretation of single-breath Carbon Monoxide Diffusing Capacity ( D L C O DL_{CO} D L CO ​ ) requires an in-depth understanding of the mathematical models governing gas transfer, the simultaneous measurement of Alveolar Volume ( V A V_A V A ​ ) , and the physiological variables that modify carbon monoxide binding kinetics. Because D L C O DL_{CO} D L CO ​ reflects both the anatomical membrane thickness and the functional mass of circulating hemoglobin in the pulmonary capillaries, raw measured values must be adjusted for hemoglobin concentration ( H b Hb H b ) , carboxyhemoglobin ( C O H b COHb CO H b ) , and barometric pressure / altitude ( P B P_B P B ​ ) . This section details the equations, correction factors, and diagnostic algorithms required for the NBRC CPFT examination.

The Krogh Equation and Mathematical Derivation of DLCO

Single-breath D L C O DL_{CO} D L CO ​ is calculated using the modified Krogh equation, which expresses gas diffusion as a first-order logarithmic rate of CO disappearance from alveolar gas during the breath-hold period: D L C O = V A × 60 t × ( P B − P H 2 O ) × ln ⁡ ( F A , C O , 0 F A , C O , t ) DL_{CO} = \frac{V_A \times 60}{t \times (P_B - P_{H2O})} \times \ln \left( \frac{F_{A,CO,0}}{F_{A,CO,t}} \right) D L CO ​ = t × ( P B ​ − P H 2 O ​ ) V A ​ × 60 ​ × ln ( F A , CO , t ​ F A , CO , 0 ​ ​ )

Where:

D L C O DL_{CO} D L CO ​ : Diffusing capacity in mL CO (STPD)/min/mmHg \text{mL CO (STPD)/min/mmHg} mL CO (STPD)/min/mmHg (or SI units of mmol/min/kPa \text{mmol/min/kPa} mmol/min/kPa ).

V A V_A V A ​ : Total alveolar gas volume present during the breath-hold, expressed in Liters STPD (Standard Temperature and Pressure, Dry) for diffusion calculations, derived from V A V_A V A ​ in Liters BTPS .

t t t : Breath-hold time in seconds (measured by the Jones-Meade method), multiplied by 60 to convert to minutes.

P B − P H 2 O P_B - P_{H2O} P B ​ − P H 2 O ​ : Dry barometric pressure ( P B − 47 mmHg P_B - 47\text{ mmHg} P B ​ − 47 mmHg at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ).

F A , C O , 0 F_{A,CO,0} F A , CO , 0 ​ : Initial fractional concentration of CO in the alveoli at the start of the breath-hold (calculated from tracer gas dilution).

F A , C O , t F_{A,CO,t} F A , CO , t ​ : Final fractional concentration of CO in the exhaled alveolar gas sample after breath-hold time t t t .

Determination of Initial Alveolar CO Concentration ( F A , C O , 0 F_{A,CO,0} F A , CO , 0 ​ )

Because inspired test gas dilutes upon entering the Residual Volume of the lungs, the initial alveolar CO concentration cannot be measured directly. Instead, it is calculated from the dilution ratio of the inert, non-absorbable tracer gas (e.g., Helium or Methane): F A , C O , 0 F I , C O = F A , tracer F I , tracer ⟹ F A , C O , 0 = F I , C O × ( F A , tracer F I , tracer ) \frac{F_{A,CO,0}}{F_{I,CO}} = \frac{F_{A,\text{tracer}}}{F_{I,\text{tracer}}} \implies F_{A,CO,0} = F_{I,CO} \times \left( \frac{F_{A,\text{tracer}}}{F_{I,\text{tracer}}} \right) F I , CO ​ F A , CO , 0 ​ ​ = F I , tracer ​ F A , tracer ​ ​ ⟹ F A , CO , 0 ​ = F I , CO ​ × ( F I , tracer ​ F A , tracer ​ ​ )

Where F I , C O F_{I,CO} F I , CO ​ and F I , tracer F_{I,\text{tracer}} F I , tracer ​ represent the inspired concentrations of CO ( 0.3 % 0.3\% 0.3% ) and tracer gas ( 10 % He 10\% \text{ He} 10% He ), and F A , tracer F_{A,\text{tracer}} F A , tracer ​ is the concentration of tracer gas measured in the exhaled alveolar sample.

Alveolar Volume ( V A V_A V A ​ ) Determination and Single-Breath vs. Plethysmographic TLC

Simultaneously during the single-breath D L C O DL_{CO} D L CO ​ maneuver, Alveolar Volume ( V A V_A V A ​ ) is measured using the single-breath tracer gas dilution principle: V A = [ V I × ( F I , tracer F A , tracer ) − V D ] × BTPS Factor V_A = \left[ V_I \times \left( \frac{F_{I,\text{tracer}}}{F_{A,\text{tracer}}} \right) - V_D \right] \times \text{BTPS Factor} V A ​ = [ V I ​ × ( F A , tracer ​ F I , tracer ​ ​ ) − V D ​ ] × BTPS Factor

Where V I V_I V I ​ is the inspired volume and V D V_D V D ​ is the dead-space volume of the mouthpiece and apparatus.

Physiological Significance of V A V_A V A ​ Discrepancies

In healthy subjects with uniform ventilation, V A V_A V A ​ measured by single-breath dilution closely equals the Total Lung Capacity ( T L C TLC T L C ) measured via body plethysmography or multi-breath helium dilution ( V A ≈ T L C V_A \approx TLC V A ​ ≈ T L C ).

However, in patients with severe obstructive lung disease (e.g., emphysema, chronic bronchitis, severe asthma, or bullous lung disease):

Gas mixing is extremely maldistributed, and poorly ventilated or trapped bullous gas spaces do not equilibrate with inspired tracer gas during a brief 10-second breath-hold.

Consequently, single-breath V A V_A V A ​ significantly underestimates true TLC ( V A < T L C pleth V_A < TLC_{\text{pleth}} V A ​ < T L C pleth ​ ).

Technologists must recognize that an artificially reduced V A V_A V A ​ due to airflow obstruction will falsely lower the absolute calculated D L C O DL_{CO} D L CO ​ value, even if the alveolar-capillary membrane itself is normal.

The Krogh Factor ( D L C O / V A DL_{CO}/V_A D L CO ​ / V A ​ Ratio or K C O K_{CO} K CO ​ )

To differentiate whether a low D L C O DL_{CO} D L CO ​ is caused by loss of intrinsic alveolar-capillary tissue or simply by a reduction in lung volume, clinicians evaluate the D L C O / V A DL_{CO}/V_A D L CO ​ / V A ​ ratio (also termed the Krogh factor or K C O K_{CO} K CO ​ ): Krogh Factor ( K C O ) = D L C O V A \text{Krogh Factor } (K_{CO}) = \frac{DL_{CO}}{V_A} Krogh Factor ( K CO ​ ) = V A ​ D L CO ​ ​

Diagnostic Interpretation Algorithms

Low D L C O DL_{CO} D L CO ​ with Low D L C O / V A DL_{CO}/V_A D L CO ​ / V A ​ Ratio ( K C O K_{CO} K CO ​ ):

Indicates true loss or destruction of the alveolar-capillary membrane unit, thickening of the interstitial membrane, or loss of pulmonary capillary blood flow.

Clinical Differential Diagnoses:

Parenchymal Interstitial Lung Disease (ILD): Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis, Asbestosis, Systemic Sclerosis.

Emphysema: Destruction of alveolar walls and capillary beds (differentiates emphysema from chronic bronchitis/asthma, which typically have normal D L C O DL_{CO} D L CO ​ ).

Pulmonary Vascular Disease: Primary Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Embolism.

Low D L C O DL_{CO} D L CO ​ with Normal or Elevated D L C O / V A DL_{CO}/V_A D L CO ​ / V A ​ Ratio ( K C O K_{CO} K CO ​ ):

Indicates that the intrinsic alveolar-capillary membrane structure per unit of lung volume is healthy, but total accessible lung volume is restricted.

Clinical Differential Diagnoses:

Extrapulmonary Restriction: Kyphoscoliosis, chest wall deformities, diaphragm paralysis, neuromuscular disease (ALS, Myasthenia Gravis, Guillain-Barré).

Surgical Resection: Post-pneumonectomy or lobectomy (remaining lung tissue exhibits normal diffusion density and hyperperfusion).

Submaximal Inspiration: Patient failed to inspire to true TLC during testing ( V I < 85 % V C V_I < 85\% VC V I ​ < 85% V C ).

Elevated D L C O DL_{CO} D L CO ​ ( > 120 % to 140 % > 120\% \text{ to } 140\% > 120% to 140% of Predicted):

Reflects increased pulmonary capillary blood volume ( V c V_c V c ​ ) or enhanced hemoglobin binding.

Clinical Differential Diagnoses:

Bronchial Asthma: Increased negative intrathoracic pressures and hyperperfusion recruit apical capillaries.

Acute Pulmonary Hemorrhage: Goodpasture syndrome, Granulomatosis with Polyangiitis (Wegener's)—free RBCs in alveolar spaces absorb CO rapidly.

Polycythemia: Elevated circulating hemoglobin concentration.

Left-to-Right Cardiac Shunts: Increased pulmonary blood flow (e.g., ASD, VSD).

Supine Posture or Exercise: Increased venous return and capillary recruitment.

Hemoglobin (Hb) Corrections

Carbon monoxide uptake is directly dependent on the concentration of functional hemoglobin in pulmonary capillary blood. Anemia reduces the available binding sites, lowering measured D L C O DL_{CO} D L CO ​ , whereas polycythemia increases binding sites and elevates D L C O DL_{CO} D L CO ​ .

Standard ATS/ERS Hemoglobin Adjustment Formulas

To compare a patient's measured D L C O DL_{CO} D L CO ​ against population predicted norms, the measured D L C O DL_{CO} D L CO ​ must be adjusted to a standardized reference hemoglobin concentration:

Reference Hb for Adolescent/Adult Males ( ≥ 15 years \ge 15\text{ years} ≥ 15 years ): 14.6 g/dL 14.6\text{ g/dL} 14.6 g/dL

Reference Hb for Adult Females and Children ( < 15 years < 15\text{ years} < 15 years ): 13.4 g/dL 13.4\text{ g/dL} 13.4 g/dL Adult / Adolescent Males ( ≥ 15 yrs ) : D L C O , adjusted = D L C O , measured × [ 10.22 + H b 1.7 × H b ] \text{Adult / Adolescent Males } (\ge 15\text{ yrs}): \quad DL_{CO,\text{adjusted}} = DL_{CO,\text{measured}} \times \left[ \frac{10.22 + Hb}{1.7 \times Hb} \right] Adult / Adolescent Males ( ≥ 15 yrs ) : D L CO , adjusted ​ = D L CO , measured ​ × [ 1.7 × H b 10.22 + H b ​ ] Adult Females and Children ( < 15 yrs ) : D L C O , adjusted = D L C O , measured × [ 9.38 + H b 1.7 × H b ] \text{Adult Females and Children } (< 15\text{ yrs}): \quad DL_{CO,\text{adjusted}} = DL_{CO,\text{measured}} \times \left[ \frac{9.38 + Hb}{1.7 \times Hb} \right] Adult Females and Children ( < 15 yrs ) : D L CO , adjusted ​ = D L CO , measured ​ × [ 1.7 × H b 9.38 + H b ​ ]

Clinical Impact: In an anemic patient ( H b = 8.0 g/dL Hb = 8.0\text{ g/dL} H b = 8.0 g/dL ), the measured D L C O DL_{CO} D L CO ​ will be artificially low; applying the correction formula elevates the D L C O DL_{CO} D L CO ​ to reflect what the diffusing capacity would be if hemoglobin were normal.

  • Carboxyhemoglobin (COHb) and Altitude / Barometric Pressure Corrections
  • Carboxyhemoglobin ( C O H b COHb CO H b ) Correction

Cigarette smoking or environmental exposure elevates blood C O H b COHb CO H b . Elevated C O H b COHb CO H b impacts D L C O DL_{CO} D L CO ​ via two distinct mechanisms:

Anemia Effect: C O H b COHb CO H b ties up hemoglobin binding sites, reducing functional H b Hb H b capacity.

Back-Pressure Effect: Dissolved CO in capillary blood reduces the partial pressure gradient between alveolar gas and capillary plasma.

Rule of Thumb: Every 1 % 1\% 1% increase in blood C O H b COHb CO H b reduces measured D L C O DL_{CO} D L CO ​ by approximately 1 % 1\% 1% .

ATS/ERS Back-Pressure Correction Formula: D L C O , COHb adjusted = D L C O , measured 1 − ( % C O H b 100 ) DL_{CO,\text{COHb adjusted}} = \frac{DL_{CO,\text{measured}}}{1 - \left( \frac{\%COHb}{100} \right)} D L CO , COHb adjusted ​ = 1 − ( 100 % CO H b ​ ) D L CO , measured ​ ​

Altitude and Barometric Pressure ( P B P_B P B ​ ) Correction

At high altitude, atmospheric barometric pressure ( P B P_B P B ​ ) is significantly reduced compared to sea level ( 760 mmHg 760\text{ mmHg} 760 mmHg ).

Lower P B P_B P B ​ reduces the alveolar partial pressure of oxygen ( P A , O 2 P_{A,O2} P A , O 2 ​ ).

Lower P A , O 2 P_{A,O2} P A , O 2 ​ decreases competitive O 2 O_2 O 2 ​ occupancy of hemoglobin binding sites, causing the rate of CO binding ( θ C O \theta_{CO} θ CO ​ ) to increase.

As a result, unadjusted D L C O DL_{CO} D L CO ​ measured at high altitude is artificially elevated .

ATS Barometric Pressure Correction Formula: D L C O , sea-level equivalent = D L C O , measured × [ 1 + 0.0058 × ( P B − 760 ) ] DL_{CO,\text{sea-level equivalent}} = DL_{CO,\text{measured}} \times \left[ 1 + 0.0058 \times (P_B - 760) \right] D L CO , sea-level equivalent ​ = D L CO , measured ​ × [ 1 + 0.0058 × ( P B ​ − 760 ) ] (Note: Since P B < 760 P_B < 760 P B ​ < 760 at altitude, ( P B − 760 ) (P_B - 760) ( P B ​ − 760 ) is negative, which appropriately lowers the measured D L C O DL_{CO} D L CO ​ to its sea-level equivalent).